Herbogene Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.10 Cr
as on 05-12-2024
- Revenue %
(FY 2022)
- Profit -102.59%
(FY 2022)
- Ebitda -2099.86%
(FY 2022)
- Net Worth -63.39%
(FY 2022)
- Total Assets -3.04%
(FY 2022)
About Herbogene Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.10 Cr.
Bindu Pandey, Pramod Pandey, Arpit Pandey, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999UP2018PTC102265
- Company No.
102265
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Herbogene Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bindu Pandey  | Director | 20-Mar-2018 | Current |
| Pramod Pandey | Director | 20-Mar-2018 | Current |
| Arpit Pandey | Director | 14-Jul-2022 | Current |
| Preeti Pandey | Director | 14-Jul-2022 | Current |
Financial Performance of Herbogene Lifesciences.
Herbogene Lifesciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 102.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Herbogene Lifesciences?
Unlock access to Herbogene Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Herbogene Foods And Beverages Private LimitedActive 3 years 4 monthsBindu Pandey, Pramod Pandey and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 16 Jan 2019 | ₹1.10 Cr | Open |
How Many Employees Work at Herbogene Lifesciences?
Unlock and access historical data on people associated with Herbogene Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herbogene Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herbogene Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
